UK markets close in 7 hours 32 minutes
  • FTSE 100

    6,918.98
    -19.26 (-0.28%)
     
  • FTSE 250

    22,293.99
    -70.88 (-0.32%)
     
  • AIM

    1,260.77
    -2.92 (-0.23%)
     
  • GBP/EUR

    1.1520
    +0.0007 (+0.06%)
     
  • GBP/USD

    1.3885
    +0.0042 (+0.31%)
     
  • BTC-GBP

    34,544.66
    -4,872.16 (-12.36%)
     
  • CMC Crypto 200

    1,088.97
    -154.08 (-12.40%)
     
  • S&P 500

    4,134.98
    -38.44 (-0.92%)
     
  • DOW

    33,815.90
    -321.41 (-0.94%)
     
  • CRUDE OIL

    61.93
    +0.50 (+0.81%)
     
  • GOLD FUTURES

    1,784.10
    +2.10 (+0.12%)
     
  • NIKKEI 225

    29,020.63
    -167.54 (-0.57%)
     
  • HANG SENG

    29,037.16
    +281.82 (+0.98%)
     
  • DAX

    15,283.92
    -36.60 (-0.24%)
     
  • CAC 40

    6,268.67
    +1.39 (+0.02%)
     

Hematology Diagnostics Market to Reach $9.6 Billion by 2027

ReportLinker
·27-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 7. - Influencer Pool: 5448. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, April 02, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Hematology Diagnostics Industry" - https://www.reportlinker.com/p05960968/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Hematology Diagnostics Market to Reach $9.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Hematology Diagnostics estimated at US$6.6 Billion in the year 2020, is projected to reach a revised size of US$9.6 Billion by 2027, growing at aCAGR of 5.5% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$3.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 8.5% CAGR
- The Hematology Diagnostics market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

- Select Competitors (Total 43 Featured) -

  • Abbott Laboratories

  • Beckman Coulter, Inc.

  • F. Hoffmann-La Roche AG

  • Mindray Medical International Ltd.

  • Siemens Healthineers

  • Sysmex Corporation




Read the full report: https://www.reportlinker.com/p05960968/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Hematology
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Hematology Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Hematology Diagnostics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Blood count by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Blood count by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Blood count by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Platelet function
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Platelet function by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Platelet function by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Hemoglobin by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Hemoglobin by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Hemoglobin by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hematocrit by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Hematocrit by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Hematocrit by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Diagnostic labs
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Diagnostic labs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Diagnostic labs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Hematology Diagnostics by
Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Hematology Diagnostics by
Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Hematology Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

CANADA
Table 40: Canada Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Hematology Diagnostics
by Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Hematology Diagnostics
by Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Hematology Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

JAPAN
Table 49: Japan Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Hematology Diagnostics
by Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Hematology Diagnostics
by Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Hematology Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

CHINA
Table 58: China Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Hematology Diagnostics
by Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Hematology Diagnostics
by Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Hematology Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

EUROPE
Table 67: Europe Current & Future Analysis for Hematology
Diagnostics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 68: Europe Historic Review for Hematology Diagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Hematology Diagnostics
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Hematology Diagnostics
by Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Hematology Diagnostics
by Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Hematology Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

FRANCE
Table 79: France Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Hematology Diagnostics
by Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Hematology Diagnostics
by Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Hematology Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

GERMANY
Table 88: Germany Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Hematology
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Instruments and Consumables for the Years 2012, 2020 &
2027

Table 91: Germany Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 92: Germany Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Hematology
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Blood count, Platelet function, Hemoglobin and Hematocrit
for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Hematology
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic labs and Other End-Uses for the Years
2012, 2020 & 2027

ITALY
Table 97: Italy Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Hematology Diagnostics
by Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 101: Italy Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Hematology Diagnostics
by Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Hematology Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 106: UK Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Hematology Diagnostics by
Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Hematology Diagnostics by
Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 113: UK Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 114: UK 15-Year Perspective for Hematology Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

SPAIN
Table 115: Spain Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 116: Spain Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 117: Spain 15-Year Perspective for Hematology Diagnostics
by Product Type - Percentage Breakdown of Value Sales for
Instruments and Consumables for the Years 2012, 2020 & 2027

Table 118: Spain Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 119: Spain Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 120: Spain 15-Year Perspective for Hematology Diagnostics
by Test Type - Percentage Breakdown of Value Sales for Blood
count, Platelet function, Hemoglobin and Hematocrit for the
Years 2012, 2020 & 2027

Table 121: Spain Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 122: Spain Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 123: Spain 15-Year Perspective for Hematology Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic labs and Other End-Uses for the Years 2012, 2020 &
2027

RUSSIA
Table 124: Russia Current & Future Analysis for Hematology
Diagnostics by Product Type - Instruments and Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 125: Russia Historic Review for Hematology Diagnostics by
Product Type - Instruments and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 126: Russia 15-Year Perspective for Hematology
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Instruments and Consumables for the Years 2012, 2020 &
2027

Table 127: Russia Current & Future Analysis for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 128: Russia Historic Review for Hematology Diagnostics by
Test Type - Blood count, Platelet function, Hemoglobin and
Hematocrit Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 129: Russia 15-Year Perspective for Hematology
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Blood count, Platelet function, Hemoglobin and Hematocrit
for the Years 2012, 2020 & 2027

Table 130: Russia Current & Future Analysis for Hematology
Diagnostics by End-Use - Hospitals, Diagnostic labs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 131: Russia Historic Review for Hematology Diagnostics by
End-Use - Hospitals, Diagnostic labs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 132: Russia 15-Year Perspective for Hematology
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic labs and Other End-Uses for the Years
2012, 2020 & 2027

REST OF EUROPE
Table 133: Rest of Europe Current & Future Analysis for
Hematology Diagnostics by Product Type - Instruments and
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 134: Rest of Europe Historic Review for Hematology
Diagnostics by Product Type - Instruments and Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 135: Rest of Europe 15-Year Perspective for Hematology
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Instruments and Consumables for the Years 2012, 2020 &
2027

Table 136: Rest of Europe Current & Future Analysis for
Hematology Diagnostics by Test Type - Blood count, Platelet
function, Hemoglobin and Hematocrit - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 137: Rest of Europe Historic Review for Hematology
Diagnostics by Test Type - Blood count, Platelet function,
Hemoglobin and Hematocrit Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 138: Rest of Europe 15-Year Perspective for Hematology
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Blood count, Platelet function, Hemoglobin and Hematocrit
for the Years 2012, 2020 & 2027

Table 139: Rest of Europe Current & Future Analysis for
Hematology Diagnostics by End-Use - Hospitals, Diagnostic labs
and Other End-Uses - Independent Analysis of Annual Sales in

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05960968/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001